Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
Chapter 1
Introduction
Chapter 1 2
1.1. INTRODUCTION
The Diels–Alder (DA) cycloaddition [4 + 2] reaction was first
described in 1928,1 is a pericyclic process (Fig. 1) involving an electron-
rich conjugated diene (4-electron component) and a electron-deficient
dienophile (2-electron component). The DA reaction is regio, diastereo
selective and also stereospecific. It can be used to generate a six-
membered ring, a substituted -bond, two new -bonds and up to four
contiguous stereogenic centres in one operation. And all of the atoms
constituting the starting materials appear in the product. The DA reaction
opened up new vistas in the field of synthetic organic chemistry, and it
duly established itself as a crucial synthetic tool.
Figure 1. The fundamental mechanism of Diels-Alder reaction
Mechanistically, DA reaction requires overlap of molecular orbitals
(MO). Overlap between the highest occupied molecular orbital of the diene
(HOMO) and the lowest unoccupied molecular orbital of the dienophile
(LUMO) is thermally allowed, provided the orbitals are similar in energy.
Electron-withdrawing groups on the dienophile will facilitate the reaction,
Chapter 1 3
since this will lower the energy of the LUMO. Good dienophiles often bear
one or two of the following subtituents: CHO, COR, COOR, CN, C=C, Ph,
or halogen. The diene component should be as electron-rich as possible.
DA reactions can take place either thermally, at ambient, elevated
temperatures,2 or by Lewis acids (LA) catalyst at lower temperatures.3
Figure 2. Molecular Orbital Overlap of Diels-Alder reaction
1.1.1. Regioselectivity in DA
One of the most valuable aspects of the DA reactions in organic
synthesis is high predictable regioselectivity. Although the DA reaction of
an unsymmetrical substituted diene with an unsymmetrical substituted
dienophile can give rise to a mixture of two regioisomers, one of the two
regioisomers is formed exclusively or predominantly in many cases. The
ratio of the two regio adducts depends on the nature of the reactants,
reaction conditions, and directing effects of the substituents on the diene
and dienophile components.4 DA reaction of a substituted dienes with
substituted dienophiles, substituents on the terminus of the diene unit
favor the formation of ortho adducts, whereas the same substituents on
Chapter 1 4
the terminal carbons favor formation of para adducts. The overall directing
effects of 1, 3-disubstituted dienes are synenergic as opposed to being
antagonistic for the 1, 4 or 2, 3-disubstituted dienes. Similar analogies are
applicable for the dienophile counterpart. When these regiodirecting
factors can not dictate any overall regiochemical bias in the reaction, both
regioadducts will form in comparable quantities.
Figure 3. Regioisomerism in the Diels-Alder reaction
1.1.2. Stereoselectivity in DA
Two different modes of addition, endo and exo orientations can be
envisioned for the two components of DA reaction when they approach
each other in presumably parallel planes in the transition state (TS).5
These two modes of addition and the resulting configurational outcome are
illustrated in Figure 4. As the consequence of regio and stereoisomerism,
the DA reaction of an unsymmetrical substituted achiral diene and
unsymmetrical substituted achiral dienophile give rise, in principle, to 8
isomeric adducts (Figure 5).4 Despite this, often one diastereomer is
Chapter 1 5
produced selectively over the other isomers. In cases when the selectivity
is modest, change in the reaction condition, variation of the subtituents
and connecting the reacting partners are the means to enhance the
selectivity.
Figure 4. endo and exo addition modes in Diels-Alder reaction
Figure 5. Different modes of addition of unsymmetrically substituted
diene and dieophile in Diels-Alder reaction.
1.2. Natural products synthesis
Chapter 1 6
Natural product synthesis has been a very exciting and challenging
branch of organic chemistry in view of its creativity and unlimited scope.
Natural product synthesis witnessed an exceptional growth and many
innovative developments, especially during 20th
century.6
The most
attractive feature of natural products is the inspiring structural diversity
present in them in terms of number and size of rings, extent and range of
functionalization and number of stereogenic centers. Over the past
century, the achievements in the total synthesis of natural products have
been most astonishing.7-12
1.3. Applications of Diels-Alder reaction in Natural products Synthesis
As a representative highly stereoselective cycloaddition reaction, the
Diels–Alder reaction is the most widely explored pericyclic reaction for the
assembly of functionalized six-membered carbocyclic and heterocyclic
compounds. In addition to the assembly of monocyclic six-membered
systems, polycyclic compounds containing a variety of functionalities are
also achieved by Diels–Alder approaches. The significant usefulness of
Diels–Alder reactions has been validated in many instances through the
syntheses of structurally complex natural products. Diels-alder reaction
was extensively utilized in the synthesis of various classes of natural
products. i.e. terpenoids, alkaloids, polyketides and drugs belongs to
different class of therapeutic areas.
1.3.1. Terpenoids
Chapter 1 7
Terpenoids consist of a vast, diverse group of natural products and
present in the various forms in the most of the organisms where they fulfill
a broad range of functions. Terpenoid natural products have been reported
to act as toxins, growth inhibitors, or deterrents to microorganisms and
animals that protection against enemies may indeed be their primary role
in nature. For example, various monoterpenes (C10) are toxic to insects,13
fungi14 and bacteria15 and serve as feeding deterrents to mollusks,16
insects17 and mammals.18 The synthesis of terpenoids is most challenging,
because of their complex structures. And syntheses of various terpenoids
have been achieved successfully by Diels-Alder approach.19-25
Figure 6. Terpenoids synthesized by Diels-Alder approach
1.3.2. Alkaloids
Chapter 1 8
Alkaloids are a chemically heterogenous group of basic nitrogen
containing substances found predominantly in plants, animals,
microorganisms and marine organisms. Alkaloids are chemically,
biologically and commercially significant natural products. Among the
chemical classes present in medicinal plant species, alkaloids stand as a
class of major importance in the development of new drugs and have been
identified as responsible for pharmacological properties26 of medicinal
plants. Because of their complex structure in nature synthesis of alkaloids
is very challenging and the Diels-Alder strategy has been proved to be one
of the best methods to generate various class of alkaloids.19, 27-32
Figure 7. Alkaloids synthesized by Diels-Alder approach.
1.3.3. Polyketides
Chapter 1 9
Polyketides are secondary metabolites, exhibiting significant
diversity both in terms of their structure and function. Polyketide natural
products are known to possess a wealth of pharmacologically important
activities33-38 (antimicrobial, antifungal, antiparasitic, antitumor and
agrochemical properties). The wide spectrum of acticvity of polyketides
makes them economically, clinically and industrially the most important
molecules. And the Diels-Alder strategy has been utilized extensively in the
synthesis of this class of natural products.39- 44
Figure 8. Polyketides synthesized by Diels-Alder approach.
Chapter 1 10
1.3.4. Molecules with Pharmaceutical interest (Drugs)
The Diels-Alder reaction is firmly entrenched as one of the most
versatile synthetic transformations in organic chemistry. Numerous
examples attest to its broad utility for the preparation of natural and
unnatural products. Seventy years have gone since its discovery, and yet
investigations into its mechanistic nuances and construction potential
continue unabated. Indeed [4 + 2] cycloadditions appear to be the most
widely used method for the synthesis for simple and complex natural
products and molecules with pharmaceutical interest.45-50
Figure 9. Drugs synthesized by Diels-Alder approach.
Chapter 1 11
1.3.4.1. Synthesis of (-)-Oseltamivir 35
(-)-Oseltamivir (tamiflu) is a potent inhibitor of neuraminidase and is
used worldwide as a drug for influenza of both type A and type B.51 The
recent spread of the avian virus H5N1 has prompted governments to store
tamiflu as a precautionary measure against an influenza pandemic.
However, the high cost of the drug makes it difficult for developing
countries to stock tamiflu. Currently, tamiflu is marketed by Roche and is
prepared by a semisynthetic approach starting from (-)-shikimic acid,
which has a limited resource given the massive demand.52 Therefore, the
development of alternative synthetic approaches, which start from simple
materials, has drawn extensive attention and there are numerous reports
on the development of chemical syntheses of tamiflu from simple starting
materials.52 Among them, E. J. Corey et al., and Masakatsu Shibasaki et
al. have developed an efficient Diels-Alder approaches to tamiflu.44
E. J. Corey synthesis: E. J. Corey et al.45a was the first group to report
the Diels-Alder approach to Tamiflu. They have started the synthesis with
the Diels-Alder reaction between butadiene 41 and trifluoroethyl acrylate
42 in the presence of the S-proline-derived catalyst ent - 43 to form the
adduct ent - 44. The initial Diels-Alder step is easily carried out at room
temperature on a multigram scale in excellent yield (97%) and with >97%
Chapter 1 12
ee. Followed the by synthetic manipulation of 44 in several steps, they
have achieved the total synthesis of Tamiflu (scheme 1).
Scheme 1. E. J. Corey‟s approach to Tamiflu.
Shibasaki synthesis: Masakatsu Shibasaki et al.45b have synthesized the
Hydroxydiacyl azide 50 through the Diels–Alder reaction between
commercially available 1-(trimethylsiloxy)- 1,3-butadiene 48 and fumaryl
chloride 49, followed by TMSN3 addition in the presence of a catalytic
amount of DMAP, and acidic cleavage of trimethylsilyl ether.
Subsequently, they converted the azide 50 in to Tamiflu (Scheme 2).
Chapter 1 13
Scheme 2. Masakatsu Shibasaki,s Approach to Tamiflu
1.3.4.2. Synthesis of Taxol 34.
A well-celebrated application of the Diels-Alder reaction in the
context of natural products and drugs synthesis is found in the total
synthesis of the anti cancer drug taxol 34. Nicolaou et al.9a employed two
different [4+2] cycloadditions to construct each of the two six-membered
rings (A) 57 (Scheme 3) and ring (C) 64 (Scheme 4) of the taxol. Further
synthetic manipulation between 57 and 64 gave the natural product taxol
34 (Schemes 5).
Scheme 3. Synthesis of A ring of Taxol using Diels-Alder reaction
Chapter 1 14
Scheme 4. Synthesis of C ring of Taxol using Diels-Alder reaction.
Scheme 5. Total synthesis of Taxol from intermediates 60 and 64.
From the above discussion it‟s very clear that, Diels-Alder reaction is
one of the best tools to construct main core of complex natural products,
pharmaceutically important intermedietes and drugs. Our interest in
Diels-Alder reaction encouraged us to use this unique methodology to
study its synthetic uitility in exploring to eremophilane natural products,
the fungal metabolite ascochlorin and pfizers anti smoking drug
varenicline. We would like to discuss our affords in the next upcoming
three chapters.
Chapter 1 15
1.4. REFERENCES
1. Diels, O.; Alder, K. Justus Liebigs Ann. Chem. 1928, 98, 460.
2. Carruthers, W. In Cycloaddition Reactions in Organic Synthesis;
Pergamon: New York, 1990.
3. Santelli, M.; Pons, J-M. In Lewis Acids and Selectivity in Organic
Chemistry: CRC: Boca Ratom. 1995, 267.
4. Oppolzer, W. In Comprehensive Organic Synthesis; Trost, B. M.;
Fleming, I. Eds. Pergamon: Oxford, 1991, 5, 315-339.
5. Fringuelli, F.; Tatichi, A. In Diene in the Diels-Alder Reactions; Wiley
Interscience: New York, 1990.
6. (a) Flemming, I. „Selected Organic Synthesis’, Wiley, New York, 1973.
(b) Mehta G.; Nagarajan, M. „Perspective in Organic Synthesis‟,
Indian National Science Academy, 1984. (c) Bindra, J. S.;
Ranganathan, S. „Art in Organic Synthesis’, John Wiley, 1987. (d)
Corey, E.J.; Cheng, X-M. „The Logic of Chemical Synthesis’, Wiley,
New York, 1989. (e) Nicolaou, K.C.; Sorenson, E. J. „Classics in Total
Synthesis’, VCH, Weinheim, 1996. (f) Nicolaou, K. C.; Snyder, S. A.
„Classics in Total Synthesis ІІ‟, VCH, Weinheim, 2003.
7. (a) Woodward, R. B. Pure Appl. Chem. 1968, 17, 519. (b) Woodward,
R. B. Pure Appl. Chem. 1971, 25, 283. (c) Woodward, R. B. Pure
Appl. Chem. 1973, 33, 145. (d) Eshenmoser, A.; Winter, C. E.
Science 1977, 196, 1410.
Chapter 1 16
8. Kishi, Y. J. Am. Chem. Soc. 1994, 116, 11205 and references cited
therein.
9. (a) Nicolaou, K. C.; Yang. Z.; Liu, J. J.; Ueno, H.; Nantermet, P. G.;
Guy, R. K.; Claiborne, C. F.; Renaud, J.; Couladouros, E. A.;
Paulvannan, K.; Sorensen, E. J. Nature 1994, 367, 630. (b) Holton,
R, A.; Somozo, C.; Kim, K. B.; Liang, F.; Biediger, R. J.; Boatman, P.
D.; Shindo, M.; Smith, C.-C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.;
Tao, C.; Vu, P.; Tang, S.; Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu,
J. H. J. Am. Chem. Soc. 1994, 116, 1597. (c) Holtan, R, A.; Somozo,
C.; Kim, K. B.; Liang, F.; Biediger, R. J.; Boatman, P. D.; Shindo, M.;
Smith, C.-C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.; Tao, C.; Vu, P.;
Tang, S.; Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu, J. H. J. Am.
Chem. Soc. 1994, 116, 1599. (d) Danishefsky, S. J.; Master, J. J.;
Young, W. B.; Link, J. T.; Snyder, L. B.; Magee, T. V.; Jung, D. K.;
Isaacs, R. C. A.; Bornmann, W. G.; Alaimo, C. A.; Coburn, C. A.;
Grandi, M. J. D. J. Am. Chem. Soc. 1996, 118, 2843.
10. Nicolaou, K. C.; Xu, J.–Y.; Kim, S.; Ohshima, T.; Hosokawa, S.;
Pfefferkorn, J. J. Am. chem. Soc. 1997, 119, 11353. (b) Nicolaou, K.
C.; Kim, S.; Pfefferkorn, J.; Xu, J.–Y.; Ohshima, T.; Hosokawa, S.;
Vourloumis, D.; Li, T. Angew. Chem. Int. Ed. 1998, 37, 1418. (c)
Nicolaou, K. C.; Xu, J. Y.; Kim, S.; Pferfferkorn, J.; Ohshima, T.
Vourloumis, D.; Hosokawa, S. J. Am. Chem. Soc. 1998, 120, 8661.
Chapter 1 17
11. (a) Hirama, M.; Oishi, T.; Uehara, H.; Inoue, M.; Maruyama, M.;
Oguri, H.; Sakate, M. Science 2001, 294, 1904.
12. (a) Ito, H.; Hasegawa, M.; Takenaka, Y.; Kobayashi, T.; Iguchi, K. J.
Am. Chem. Soc. 2004, 126, 4520. (b) Chao, Y. S.; Carcache, D. A.;
Tian, Y.; Li, Y.-M.; Danishefsky, S. J. J. Am. Chem. Soc. 2004, 126,
14358. (c) Zapf, C. W.; Harrison, B. A.; Drahl, C.; Sorensen, E. J.
Angew. Chem. Int. Ed. 2005, 44, 6533. (d) Nicolaou, K. C.; Lim, Y. H.
Papageorgiou, C. D.; Piper, J. L. Angew. Chem. Int. Ed. 2005, 44,
7917. (e) Tisdale, E. J.; Slovodov, I.; Theodorakis, E. A. Proc. Natl.
Acad. Sci. USA. 2004, 101, 12030.
13. Lee, S.; Peterson, C. J.; Coats, J. R. J. Stored Prod. Res. 2003, 39, 77–
85.
14. Hammer, K. A.; Carson, C. F.; Riley, T.V. J. Appl. Microbiol. 2003, 95,
853–860.
15. Friedman, M.; Henika, P. R.; Mandrell, R. E. J. Food Prot. 2002, 65,
1545–1560.
16. Frank, T.; Bieri, K.; Speiser, B. Ann. Appl. Biol. 2002, 141, 93–100.
17. Szczepanik, M.; Dams, I.; Wawrzenczyk, C. Environ. Entomol. 2005,
34, 1433–1440.
18. Vourch, G. et al. J. Chem. Ecol. 2002, 28, 2411–2427.
19. For a recent review, see. Takao, K.-I.; Munakata, R.; Tadano, K.-I.
Chem. Rev. 2005, 105, 4779-4807.
Chapter 1 18
20. Taber, D. F.; Nakajima, K.; Xu, M.; Rheingold, A. L. J. Org. Chem.
2002, 67, 4501.
21. (a) Gwaltney, S. L., II; Shea, K. J. Tetrahedron Lett. 1996, 37, 949. (b)
Gwaltney, S. L., II; Sakata, S. T.; Shea, K. J. J. Org. Chem. 1996, 61,
7438.
22. (a) Suzuki, Y.; Nishimaki, R.; Ishikawa, M.; Murata, T.; Takao, K.;
Tadano, K. Tetrahedron Lett. 1999, 40, 7835. (b) Suzuki, Y.;
Nishimaki, R.; Ishikawa, M.; Murata, T.; Takao, K.; Tadano, K. J. Org.
Chem. 2000, 65, 8595.
23. Toro, A.; Nowak, P.; Deslongchamps, P. J. Am. Chem. Soc. 2000, 122,
4526.
24. Miyaoka, H.; Kajiwara, Y.; Hara, Y.; Yamada, Y. J. Org. Chem. 2001,
66, 1429.
25. Kurosu, M.; Marcin, L. R.; Grinsteiner, T. J.; Kishi, Y. J. Am. Chem.
Soc. 1998, 120, 6627.
26. (a) Kishore, N.; Mishra, B. B.; Tripathi, V.; Tiwari. V. K. Fitoterapia
2009, 80, 149–163 and reference sited therein. (b) Sharma, B.;
Salunke, R.; Balomajumder, C.; Daniel S.; Roy, P. J.
Ethnopharmacology 2010, 127, 457-462 and reference sited therein.
(c) Maisonneuve, I. M.; Glick, S. D. Pharm. Biochem and Beh. 2003,
75, 607-618 and reference sited therein. (d) M. D. Ismail, F.; Levitsky,
D. O.; Dembitsky, V. N. Eur. J. Med. Chem. 2009, 44, 3373-3387 and
Chapter 1 19
reference sited therein. (e) Gul, W.; Hamann, M. T. Life Sciences 2005,
78, 442-453 and reference sited therein.
27. (a) Jacobi, P. A.; Lee, K. J. Am. Chem. Soc. 1997, 119, 3409. (b)
Jacobi, P. A.; Lee, K. J. Am. Chem. Soc. 2000, 122, 4295.
28. Ginn, J. D.; Padwa, A. Org. Lett. 2002, 4, 1515.
29. Grieco, P. A.; Dai, Y. J. Am. Chem. Soc. 1998, 120, 5128.
30. Brosius, A. D.; Overman, L. E.; Schwink, L. J. Am. Chem. Soc. 1999,
121, 700.
31. Abe, H.; Aoyagi, S.; Kibayashi, C. J. Am. Chem. Soc. 2000, 122, 4583.
32. McCauley, J. A.; Nagasawa, K.; Lander, P. A.; Mischke, S. G.;
Semones, M. A.; Kishi, Y. J. Am. Chem. Soc. 1998, 120, 7647.
33. Edwards, M. L.; Stemreick, D. M.; Sunkara, P. S. J. Med. Chem. 1990,
33, 1948–1954.
34. Hopwood, D. A. Chem. Rev. 1997, 97, 2465–2497.
35. Jang, M. Science 1997, 275, 218–220.
36. Katz, L.; Donadia, S. Annu. Rev. Microbiol. 1993, 47, 875–912.
37. Keating, T. A.; Walsh, C. T. Curr. Opin. Chem. Biol. 1999, 3, 598–606.
38. Khosla, C.; Gokhale, R. S.; Jacobsen, J. R.; Cane, D. E. Annu. Rev.
Biochem. 1999, 68, 219–253.
39. (a) Roush, W. R.; Sciotti, R. J. J. Am. Chem. Soc. 1994, 116, 6457. (b)
Roush, W. R.; Sciotti, R. J. J. Am. Chem. Soc. 1998, 120, 7411.
40. Gaul, C.; Njardarson, J. T.; Danishefsky, S. J. J. Am. Chem. Soc.
2003, 125, 6042-6043.
Chapter 1 20
41. Vosburg, D. A.; Vanderwal, C. D.; Sorensen, E. J. J. Am. Chem. Soc.
2002, 124, 4552.
42. Tatsuta, K.; Narazaki, F.; Kashiki, N.; Yamamoto, J.; Nakano, S. J.
Antibiot. 2003, 56, 584.
43. (a) Motozaki, T.; Sawamura, K.; Suzuki, A.; Yoshida, K.; Ueki, T.;
Ohara, A.; Munakata, R.; Takao, K.; Tadano, K. Org. Lett. 2005, 7,
2261. (b) Motozaki, T.; Sawamura, K.; Suzuki, A.; Yoshida, K.; Ueki,
T.; Ohara, A.; Munakata, R.; Takao, K.; Tadano, K. Org. Lett. 2005, 7,
2265.
44. (a) Layton, M. E.; Morales, C. A.; Shair, M. D. J. Am. Chem. Soc. 2002,
124, 773. (b) Morales, C. A.; Layton, M. E.; Shair, M. D. Proc. Natl.
Acad. Sci. U.S.A. 2004, 101, 12036.
45. (a) Yeung, Y.-Y.; Hong, S.; Corey, E. J. J. Am. Chem. Soc. 2006, 128,
6310-6311. (b) Yamatsugu, K.; Kamijo, S.; Suto, Y.; Kanai, M.;
Shibasakhi, M. Tetrahedron Lett. 2007, 48, 1403-1406. (c) Satoh, N.;
Akiba, T.; Yokoshima, S.; Fukuyama, T. Angew. Chem. Int. Ed. 2007,
46, 5734-5736.
46. Ghosh, A. K.; Xi, K. Org. Lett. 2007, 9, 4013-4016.
47. Lygo, B.; Bhatia, M.; Cooke, J. W. B.; Hirst, D. Tetrahedron Lett.
2003, 44, 2529-2532.
48. (a) Auclair, K.; Sutherland, A.; Kennedy, J.; Witter, D. J.; Van den
Heever, J. P. J. Am. Chem. Soc. 2000, 122, 11519-11520. (b) Araki,
Chapter 1 21
Y.; Knoike, T. J. Org. Chem. 1997, 62, 5299-5309. (c) Ghosh, A. K.;
Lei, H. J. Org. Chem. 2000, 65, 4779-4781.
49. Scheerrer, J. R.; Lawrence, J. F.; Wang, G. C.; Evans, D. A. J. Am.
Chem. Soc. 2007, 129, 8968-8969.
50. Chackalamannil, S.; Davies, R. J.; Wang, Y.; Asberom, T.; Doller, D.;
Wong, J.; Leone, D. J. Org. Chem. 1999, 64, 1932-1940.
51. Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H.; Zhang, L.;
Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai,
C. Y.; Laver, W. G.; Stevens, R. C. J. Am. Chem. Soc. 1997, 119, 681-
690.
52. For a review that includes the extensive studies at Roche, see:
Abrecht, S.; Harrington, P.; Iding, H.; Karpf, M.; Trussardi, R.; Wirz,
B.; Zutter, U. Chimia 2004, 58, 621 – 629.
53. (a) Trost, B. M.; Zhang, T. Angew. Chem. Int. Ed. 2008, 47, 3759 –
3761. (b) Bromfield, K. M.; Graden, H.; Habberg, D. P.; Olsson, T.;
Kann, N. Chem. Commun. 2007, 3183–3185. (c) Shie, J.-J.; Fang, J.-
M.; Wang, S.-Y.; Tsai, K.-C.; Cheng, Y.-S. E.; Yang, A.-S.; Hsiao, S.-C.;
Su, C.-Y.; Wong, C.-Y. J. Am. Chem. Soc. 2007, 129, 11892-11893. (c)
Mita, T.; Fukuda, N.; Roca, F. X.; Kanai, M.; Shibasaki, M. Org. Lett.
2007, 9, 259-262. (d) Fukuta, Y.; Mita, T.; Fukuda, N.; Kanai, M.;
Shibasaki, M. J. Am. Chem. Soc. 2006, 128, 6312-6313. (e) Cong, X.;
Yao, Z.-J. J. Org. Chem. 2006, 71, 5365-5368.